Metraipolis › archive › dc_a333c8680d45
Chronic Kidney Disease in Metabolic Disease: Regulation of SGLT2 and Transcriptomic-Epigenetic Effects of Its Pharmacological Inhibition — Europe PMC PMID:41596241
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41596241
- DOI
- 10.3390/ijms27020589
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T00:42:32.812Z
- SHA-256 of the archived text
12ee17d26def298b000367300907d2e8f10975644c5eb75062b60248597ba7b2- Stable URL of this page
https://metraipolis.com/documento/dc_a333c8680d45
How to cite
Chronic Kidney Disease in Metabolic Disease: Regulation of SGLT2 and Transcriptomic-Epigenetic Effects of Its Pharmacological Inhibition — Europe PMC PMID:41596241 — Europe PMC (en), https://europepmc.org/article/MED/41596241 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a333c8680d45 (Metraipolis archive dc_a333c8680d45, sha256 12ee17d26def298b000367300907d2e8f10975644c5eb75062b60248597ba7b2)
BibTeX
@misc{dca333c8680d45,
title = {Chronic Kidney Disease in Metabolic Disease: Regulation of SGLT2 and Transcriptomic-Epigenetic Effects of Its Pharmacological Inhibition — Europe PMC PMID:41596241},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41596241},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a333c8680d45; sha256 12ee17d26def298b000367300907d2e8f10975644c5eb75062b60248597ba7b2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596241. Agents can read the archived copy with the MCP tool read_document.